Investigation by Parkinson’s Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson’s disease: further results of randomised trial and confidential inquiry

Objective: To determine whether the excess mortality observed in patients who received both levodopa and selegiline in a randomised trial could be explained by revised diagnosis of Parkinson’s disease, autonomic or cardiovascular effects, more rapid disease progression, or drug interactions. Design:...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ben-Shlomo, Y, Churchyard, A, Head, J, Hurwitz, B, Overstall, P, Ockelford, J, Lees, A J
פורמט: Artigo
שפה:Inglês
יצא לאור: British Medical Journal 1998
נושאים:
Papers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC28519/
https://ncbi.nlm.nih.gov/pubmed/9583926
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים